According to a recent comprehensive by MarkNtel Advisors Radiopharmaceuticals Market research report, the Radiopharmaceuticals market is set for significant growth, driven by factors such as market size, share, and evolving trends.
This detailed report offers crucial
insights into the market, covering key aspects such as market segmentation and
definitions. It outlines the main drivers of growth and provides a clear
forecast of the industry’s future direction. Additionally, the study provides a
thorough overview of the competitive landscape, detailing recent developments
and regional distribution across major areas. An expert competitor analysis
delivers an in-depth understanding of market dynamics, offering strategic
recommendations for businesses and investors.
With its robust analysis and
forward-looking projections, this report is an essential resource for
stakeholders aiming to leverage emerging opportunities and address potential
challenges in the Radiopharmaceuticals market.
Get a Sample PDF of
Report - https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html
Radiopharmaceuticals
Market (2024-2030): Analysis and Growth
The Global Radiopharmaceuticals Market
is estimated to grow at a CAGR of around 10.02% during the forecast period,
i.e., 2024-30.
What are the key
drivers fueling growth in the Radiopharmaceuticals market from 2024-2030?
Increasing Prevalence of Chronic Diseases
– There are a large number of patients with cardiovascular diseases globally
due to factors, such as changing lifestyles, obesity, an aging population,
improved survival rates from heart attacks and strokes, etc. For instance, the
British Heart Foundation stated in 2024 that, around 620 million, which makes 1
in 13 people, are living with heart and circulatory diseases across the world.
Radiopharmaceuticals Market : Segmentation
Analysis
-By
Radioisotope
-Technetium
99- Market Size & Forecast 2019-2030, USD Million
-Fluorine 18-
Market Size & Forecast 2019-2030, USD Million
-Iodine 131-
Market Size & Forecast 2019-2030, USD Million
-Gallium 68-
Market Size & Forecast 2019-2030, USD Million
-Iodine 123-
Market Size & Forecast 2019-2030, USD Million
-Others
(Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2019-2030, USD
Million
-By
Indication
-Oncology-
Market Size & Forecast 2019-2030, USD Million
-Cardiology-
Market Size & Forecast 2019-2030, USD Million
-Gastroenterology-
Market Size & Forecast 2019-2030, USD Million
-Nephrology-
Market Size & Forecast 2019-2030, USD Million
-Others
(Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2019-2030,
USD Million
-By Type
-Diagnostic-
Market Size & Forecast 2019-2030, USD Million
-Therapeutic-
Market Size & Forecast 2019-2030, USD Million
-By End User
-Hospitals-
Market Size & Forecast 2019-2030, USD Million
-Medical
Imaging Centers- Market Size & Forecast 2019-2030, USD Million
-Others
(Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast
2019-2030, USD Million
-By Region
-North
America
-South
America
-Europe
-The Middle
East & Africa
-Asia-Pacific
Explore the Complete
Analysis Report – https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html
What role do key
competitors play in shaping the market, and how are they adapting to emerging
trends and challenges?
Bayer AG, Iso-Tex Diagnostics, Inc.,
Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus
Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma,
Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech
Biopharma, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun
Pharmaceutical Industries, Inc.
“Market research
studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint
formats. Within 24 hours of the payment being successfully received, the report
will be sent to your email address.”
Key Report Highlights
·
Market
Dimensions & Projections
·
Pricing
Evaluation,
·
Recent
Strategic Moves by Companies,
·
Primary
Stakeholders,
·
Analysis
of Import and Export Trends,
·
Competitive
Landscape Assessment,
·
Emerging
Opportunities,
·
Market
Trends and Indicators
More Reports:
Why MarkNtel
Advisors?
MarkNtel Advisors is a leading
research, consulting, & data analytics firm that provides an extensive
range of strategic reports on diverse industry verticals. We deliver data to a
substantial & varied client base, including multinational corporations, financial
institutions, governments, & individuals, among others.
Our specialization in niche industries
& emerging geographies allows our clients to formulate their strategies in
a much more informed way and entail parameters like Go-to-Market (GTM), product
development, feasibility analysis, project scoping, market segmentation,
competitive benchmarking, market sizing & forecasting, & trend
analysis, among others, for 15 diverse industrial verticals.
For Media Inquiries,
Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut,
USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar
Pradesh-201301
No comments: